A new approach to treating pancreatic cancer using 'educated killer cells' has shown promise, according to a new study by UNSW medical researchers.
Sep 4, 2018
0
129
What if instead of daily insulin injections or wearing pumps, just getting a shot every few months could reverse Type 1 diabetes for you—or your dog?
Aug 21, 2018
0
1019
A compound discovered at Sanford Burnham Prebys Medical Discovery Institute (SBP) has advanced into a Phase 1 trial for metastatic pancreatic cancer. Called CEND-1 (scientifically known as iRGD), the compound was exclusively ...
Aug 21, 2018
0
42
A University of North Carolina Lineberger Comprehensive Cancer Center study may provide insights into how to overcome barriers to using immune-based treatments for pancreatic cancer, the third most deadly cancer in the United ...
Aug 6, 2018
0
77
A clinical trial recently showed that nearly half of individuals with type 2 diabetes achieved remission to a non-diabetic state after a weight-loss intervention delivered within 6 years of diagnosis. Now a study published ...
Aug 2, 2018
0
192
Researchers at Karolinska Institutet have discovered that one of the building blocks in the calcium channels in the pancreatic beta cells play an important role in regulating our blood glucose values. Treatments aimed at ...
Jul 25, 2018
0
101
Pancreatic cancer often spreads, forming metastases in the liver or lungs. The prognosis is better for patients with metastases in the lungs. However, the cancer cells' ability to alter their characteristics and shape influences ...
Jul 10, 2018
0
9
By instructing key immune system cells to accept transplanted insulin-producing islets, researchers have opened a potentially new pathway for treating type 1 diabetes. If the approach is ultimately successful in humans, it ...
Jun 5, 2018
0
31
Diabetes affects more than 400 million individuals worldwide. In what is becoming a paradigm shift, researchers have begun to find that the disease may result in part through pancreatic beta cells losing their functional ...
Jun 5, 2018
0
840
Patients with diabetes generally rely on constant injections of insulin to control their disease. But MIT spinout Sigilon Therapeutics is developing an implantable, insulin-producing device that may one day make injections ...
May 17, 2018
0
12
